Caplight Directory>Companies>Xaira Therapeutics-preview>Xairatherapeutics


Xaira Therapeutics

Xaira Therapeutics

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://xairatherapeutics.com/

Last Round

VC Round

Apr 23, 2024

Company Overview

Xaira Therapeutics is a biotechnology company that is developing an AI-enabled platform for drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Foundation

Keywords

AI drug discoveryAI biotechdrug discovery platformbiological foundation modelstherapeutic pipelineprotein designundruggable targetsantibody therapeuticsgenerative AI for biologycomputational biologyRFdiffusion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xaira Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Xaira Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 23, 2024
View all Funding Rounds

Xaira Therapeutics Investors

Notable investors and investment history

InvestorRounds
SV AngelVC Round
ARCH Venture PartnersVC Round
Parker Institute for Cancer ImmunotherapyVC Round
Lux CapitalVC Round
Two Sigma VenturesVC Round
Byers CapitalVC Round
Sequoia CapitalVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2024

    $1.0B round led by ARCH Venture Partners and Foresite Labs.

View all signals

Xaira Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xaira Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xaira Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Year Founded2023
Last FundingApr 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.